Surgery

Abdulla A. Attum, MD, FACS, is recognized by Continental Who's Who

Friday, September 18, 2020 - 10:35pm

Board-certified cardiothoracic surgeon, Dr. Attum has led an impressive career, having accrued many years of professional experience in his field.

Key Points: 
  • Board-certified cardiothoracic surgeon, Dr. Attum has led an impressive career, having accrued many years of professional experience in his field.
  • He specializes in open-heart procedures, off-pump bypass, valve surgery, lung and chest wall resections, and complex cardiac procedures.
  • In his current capacity, Dr. Attum is a surgeon at Pikeville Medical Center in Pikeville Kentucky demonstrating the highest level of professionalism and integrity.
  • He takes pride in maintaining the lowest complication rates, nationally, and treats all patients as if they were his family.

CMR Surgical: Versius Surgical Robotic System launched in France as CMR Surgical extends global footprint

Friday, September 18, 2020 - 12:00pm

Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS).

Key Points: 
  • Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS).
  • CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius, a next-generation surgical robot.
  • With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.
  • Founded in 2014, CMR Surgical is a private limited company backed by an international shareholder base.

CMR Surgical: Versius Surgical Robotic System launched in France as CMR Surgical extends global footprint

Friday, September 18, 2020 - 7:00am

Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS).

Key Points: 
  • Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS).
  • CMR Surgical (CMR) is a global medical devices company dedicated to transforming surgery with Versius, a next-generation surgical robot.
  • With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.
  • Founded in 2014, CMR Surgical is a private limited company backed by an international shareholder base.

AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020

Thursday, September 17, 2020 - 9:01pm

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2021 before the market open on Tuesday, September 29, 2020.

Key Points: 
  • AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2021 before the market open on Tuesday, September 29, 2020.
  • To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and refer to the passcode 13710506.
  • This conference call will also be webcast and can be accessed from the Investors section of the AngioDynamics website at www.angiodynamics.com .
  • AngioDynamics diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products.

THINK Surgical Unveils New Corporate Website

Thursday, September 17, 2020 - 7:29pm

FREMONT, Calif., Sept. 17, 2020 /PRNewswire/ -- THINK Surgical, Inc., an advanced orthopedic robot technology company, announced the official launch of its new corporate website www.thinksurgical.com .

Key Points: 
  • FREMONT, Calif., Sept. 17, 2020 /PRNewswire/ -- THINK Surgical, Inc., an advanced orthopedic robot technology company, announced the official launch of its new corporate website www.thinksurgical.com .
  • "THINK Surgical is proud to share our new and improved corporate website with patients and medical professionals who want to learn more about the orthopedic solutions we offer," saidJay Yang, acting CEO, THINK Surgical, Inc."THINK's new website chronicles the history of our company and features surgeon and patient perspectives regarding total knee replacement utilizing our active robot technology, which is truly revolutionizing orthopedic surgery."
  • THINK Surgical, Inc. is committed to the future of orthopedic surgery and to improving patient care through the development of leading-edge precision technology.
  • THINK Surgical, Inc. develops, manufactures and markets active robotics for hip and knee replacement surgery and maintains an open implant library, allowing surgeons maximum choice for their patients.

OncLive® Names the 2020 Class of Giants of Cancer Care®

Thursday, September 17, 2020 - 6:27pm

OncLive, the nations leading multimedia resource focused on providing oncology professionals with relevant, insightful information on patient care, is pleased to announce the Eighth Annual Giants of Cancer Care class of inductees.

Key Points: 
  • OncLive, the nations leading multimedia resource focused on providing oncology professionals with relevant, insightful information on patient care, is pleased to announce the Eighth Annual Giants of Cancer Care class of inductees.
  • The members of the 2020 class of Giants of Cancer Care are oncology legends who have made remarkable differences in the cancer care landscape, said Mike Hennessy Jr., president and CEO of MJH Life Sciences, the parent company of OncLive.
  • This years Giants of Cancer Care inductees by award category are:
    Breast Cancer Martine J. Piccart, M.D., Ph.D., Universit Libre de Bruxelles and Jules Bordet Institute.
  • Out of 818 nominations, only 15 oncologists were selected to the prestigious 2020 class of Giants of Cancer Care.

Contemporary OB/GYN® Deputy Editor Honored with Distinguished Surgeon Award from Society of Gynecologic Surgeons

Thursday, September 17, 2020 - 3:21pm

Contemporary OB/GYN, a multimedia platform that provides obstetricians and gynecologists with expert advice and critical articles from top-tier physician-authors, is excited to announce that deputy editor, Jon I. Einarsson, MD, MPH, has been honored with the Distinguished Surgeon Award by The Society of Gynecologic Surgeons (SGS).

Key Points: 
  • Contemporary OB/GYN, a multimedia platform that provides obstetricians and gynecologists with expert advice and critical articles from top-tier physician-authors, is excited to announce that deputy editor, Jon I. Einarsson, MD, MPH, has been honored with the Distinguished Surgeon Award by The Society of Gynecologic Surgeons (SGS).
  • Einarsson has served as deputy editor of Contemporary OB/GYN since 2011.
  • The Distinguished Surgeon Award winner is selected by the current SGS president, based on contributions to the field of gynecologic surgery clinically and/or through research and innovation.
  • First presented in 1985, the honor of the Distinguished Surgeon Award is granted to an individual who has made a positive impact to the field of gynecologic surgery or mentoring.

Titan Medical Announces Intellectual Property Portfolio Expansion with Issuance of Robotic Surgery Patents Related to Camera and System Control

Thursday, September 17, 2020 - 1:00pm

The Company has also received notices of allowance in 17 other patent applications and accordingly anticipates their issuance in the coming months.

Key Points: 
  • The Company has also received notices of allowance in 17 other patent applications and accordingly anticipates their issuance in the coming months.
  • 10,772,703 titled Methods and apparatuses for positioning a camera of a surgical robotic system to capture images inside a body cavity of a patient during a medical procedure and U.S. Patent No.
  • 10,758,311 titled Hand controller apparatus for gesture control and shared input control in a robotic surgery system.
  • Titan intends to initially pursue gynecologic surgical indications for use with its single-port robotic surgical system.

VBI Vaccines Announces Biomarker Data From VBI-1901 Phase 1/2a Study in Recurrent GBM Presented at ESMO Virtual Congress 2020

Thursday, September 17, 2020 - 1:00pm

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced additional biomarker data from its ongoing Phase 1/2a study evaluating VBI-1901, the companys cancer vaccine immunotherapeutic candidate in recurrent glioblastoma (GBM) patients presented in an e-poster at The European Society for Medical Oncology (ESMO) Virtual Congress 2020.

Key Points: 
  • VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced additional biomarker data from its ongoing Phase 1/2a study evaluating VBI-1901, the companys cancer vaccine immunotherapeutic candidate in recurrent glioblastoma (GBM) patients presented in an e-poster at The European Society for Medical Oncology (ESMO) Virtual Congress 2020.
  • As with the previously announced CD4+/CD8+ ratio, a biomarker which may reflect the immunologic fitness of CD4+ T cells in recurrent GBM patients, these biomarkers will continue to be evaluated throughout the study.
  • This phase enrolled 18 recurrent GBM patients across three dose cohorts of VBI-1901: 0.4 g, 2.0 g, and 10.0 g.
    Enrollment completed in December 2018.
  • VBI is headquartered in Cambridge, MA, with research operations in Ottawa, Canada, and research and manufacturing facilities in Rehovot, Israel.

True Digital Surgery and Aesculap AG Launch the Aesculap Aeos® Robotic Digital Microscope

Thursday, September 17, 2020 - 6:05am

Breakthrough platform utilizes 3D digital visualization, state-of-the-art software and augmentation capabilities that are unmatched by any competitor digital microscope platforms

Key Points: 
  • Breakthrough platform utilizes 3D digital visualization, state-of-the-art software and augmentation capabilities that are unmatched by any competitor digital microscope platforms
    GOLETA, California, Sept. 17, 2020 /PRNewswire/ --True Digital Surgery (TDS) today announced that the Aesculap Aeos Robotic Digital Microscope is now available in the U.S., Europe and other regions of the world.
  • To develop the Aesculap Aeos Robotic Digital microscope, True Digital Surgery partnered with the AESCULAP subsidiary of B. Braun, a global company with an over 150-year legacy in developing, manufacturing and marketing innovative medical products and services to the healthcare industry.
  • Aesculap focuses on the following therapeutic areas: abdominal surgery, cardiothoracic surgery, orthopedic surgery, spine surgery, neurosurgery, interventional vascular therapy and sterile goods management.
  • With products like the Aesculap Aeos Robotic Digital Microscope Platform, the company strives for innovations which result in medical advances.